Preferred antiretroviral drugs for the next decade of scale up

Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda

(2013) Edward J. Mills et al.   ANNALS OF INTERNAL MEDICINE

Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents

(2012) Roger Bedimo et al.   AIDS

Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement

(2012) Keith W Crawford et al.   LANCET INFECTIOUS DISEASES

Getting HIV Treatment to the Most People

(2012) S. Lynch et al.   SCIENCE

Safety of efavirenz in the first trimester of pregnancy

(2011) Nathan Ford et al.   AIDS

Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach? [Review article]

(2011) A. Loeliger et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review

(2011) Katharina Kranzer et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients

(2010) Ryan D. Cooper et al.   CLINICAL INFECTIOUS DISEASES

Improving first-line antiretroviral therapy in resource-limited settings

(2009) Nathan Ford et al.   Current Opinion in HIV and AIDS

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

(2008)   LANCET